Endothelial cells-directed angiogenesis in colorectal cancer : Interleukin as the mediator and pharmacological target

dc.contributor.author	Cui, Guanglin
dc.contributor.author	Liu, Hanzhe
dc.contributor.author	Laugsand, Jann-Birger
dc.date.accessioned	2023-02-01T13:57:35Z
dc.date.available	2023-02-01T13:57:35Z
dc.date.created	2023-01-24T13:18:55Z
dc.date.issued	2022
dc.identifier.citation	Cui, G., Liu, H. & Laugsand, J.-B. (2022). Endothelial cells-directed angiogenesis in colorectal cancer: Interleukin as the mediator and pharmacological target. International Immunopharmacology, 114, Article 109525. doi:	en_US
dc.identifier.issn	1878-1705
dc.identifier.uri	https://hdl.handle.net/11250/3047774
dc.description	Author's accepted version (postprint).	en_US
dc.description	This is an Accepted Manuscript of an article published by Elsevier in International Immunopharmacology on 9 Dec 2022.	en_US
dc.description	Available online: https://www.sciencedirect.com/science/article/pii/S1567576922010104?via%3Dihub	en_US
dc.language.iso	eng	en_US
dc.publisher	Elsevier	en_US
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/deed.no	*
dc.title	Endothelial cells-directed angiogenesis in colorectal cancer : Interleukin as the mediator and pharmacological target	en_US
dc.type	Peer reviewed	en_US
dc.type	Journal article	en_US
dc.description.version	acceptedVersion	en_US
dc.source.volume	114	en_US
dc.source.journal	International Immunopharmacology	en_US
dc.identifier.doi	10.1016/j.intimp.2022.109525
dc.identifier.cristin	2114030
dc.source.articlenumber	109525	en_US

Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal